Natural Antisense and RNP-4F Expression in Drosophila
果蝇中的天然反义和 RNP-4F 表达
基本信息
- 批准号:6752654
- 负责人:
- 金额:$ 20.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Drosophila RNP4F is an ortholog to human p110, which functions with the pre-mRNA processing (PRP) protein class as a recycling factor to carry U4 and U6-snRNPs to the assembling spliceosome. Both inherited and acquired defects in premRNA processing are being increasingly recognized as causes of human diseases. A notable example of a relatively common (and also relevant to this proposal) human genetic disease which has been shown to be due to mutations in three different PRP genes is retinitis pigmentosa (RP), affecting 1 in 4000 individuals, being characterized by progressive retinal degeneration and eventually total blindness. Our previous work has shown that rnp-4f mRNAs undergo alternative splicing; which suggests that RNP-4F may have other functions, perhaps related to those carded out by the fully spliced gene product. We outline plans to characterize alternative RNP-4F proteins and their functions, and anticipate that the results may lead to discovery of corresponding alternative p110 functions in humans. Specifically, we propose to: (a) fully identify all rnp.4f transcript isoforms and determine their in situ localizations; (b) determine in situ localizations for the correspondingly encoded proteins; (c) eliminate each mRNA isoform specifically using RNAi in an attempt to determine functions for the encoded RNP-4F isoforms; and (d) identify neighbor proteins for the different RNP-4F isoforms via yeast two-hybrid screens. We have previously reported existence of extensively A-to-G edited rnp-4f mRNA in an adult head cDNA clone, which was subsequently shown to have arisen due to the action of dADAR editase on double-stranded RNA in which the antisense strand was supplied by a developmentally regulated readthrough transcript class of the sas10 gene. A decline in rnp-4f mRNA levels was observed to accompany rising readthrough transcript levels, suggesting a role for the antisense RNA in posttranscriptional regulation of rnp-4f gene expression during development. In this proposal, we outline plans to determine the relationship between long natural antisense transcripts and gene expression control in the Drosophila rnp-4f/sas10 model gene pair. We will do this by: (a) showing that sas10 readthrough transcripts are required for the observed decline in rnp-4f mRNA levels; (b) showing that sas10 readthrough transcripts co-localize with rnp-4f mRNAs; and (c) evaluating mechanisms for rnp-4f decay: (1) dADAR editase transcript modification followed by degradation and (2) destruction via the RNAi pathway. This research will provide a basis for understanding the role of long natural antisense RNAs in posttranscriptional control of eukaryotic gene expression, and may provide a model for elucidation of roles for comparable RNAs in organisms including humans, estimated to contain about 800 such transcripts. This work will also lead: to elucidation of alternative RNP-4F functions: perhaps to discovery of corresponding alternative p110 functions in humans.
描述(由申请人提供):果蝇RNP4F是人类p110的直系同源物,它与MRNA加工前(PRP)蛋白类别一起起作用,是将U4和U6-SNRNP携带到组装剪接体的回收因子。在premrna处理中,遗传和获得的缺陷越来越被认为是人类疾病的原因。一个相对常见的人类遗传疾病的一个值得注意的例子(也与该提案相关),该疾病已证明是由于三种不同的PRP基因突变引起的,是色素性视网膜炎(RP),影响4000个个体中的1个,其特征是进行性视网膜退化和最终的全盲。我们以前的工作表明,RNP-4F mRNA经历了替代剪接。这表明RNP-4F可能具有其他功能,也许与完全剪接的基因产物夹住的功能有关。 我们概述了表征替代RNP-4F蛋白及其功能的计划,并预测结果可能会导致人类中相应的替代p110功能。具体而言,我们建议:(a)充分识别所有RNP.4F转录本同工型并确定其原位定位; (b)确定相应编码的蛋白质的原位定位; (c)消除每个mRNA同工型,特异性使用RNAi,以确定编码的RNP-4F同工型的功能; (d)通过酵母两杂交筛网鉴定不同RNP-4F同工型的邻居蛋白。我们先前曾报道过在成年头部cDNA克隆中存在广泛的A到G编辑的RNP-4F mRNA,随后由于达达尔编辑酶对双链链RNA的作用而显示出出现,在该RNA上,反义链由SAS10 Gene的开发调节的读取型转录类提供。观察到RNP-4F mRNA水平的下降伴随着读取的转录水平上升,这表明反义RNA在发育过程中RNP-4F基因表达的转录后调节中起作用。在此提案中,我们概述了果蝇RNP-4F/SAS10模型基因对中长的自然反义转录本与基因表达控制之间的关系。我们将通过:(a)表明SAS10读取的转录本是RNP-4F mRNA水平下降所必需的; (b)表明SAS10读取转录本与RNP-4F mRNA共定位; (c)评估RNP-4F衰减的机制:(1)DADAR编辑酶的转录本修改,然后降解和(2)通过RNAi途径破坏。这项研究将为理解长自然反义RNA在真核基因表达的转录后控制中的作用提供基础,并可能为阐明包括人类在内的生物体中可比RNA的作用提供模型,包括人类,估计包含约800个此类转录本。这项工作还将导致:阐明替代性RNP-4F功能:可能发现人类中相应的替代p110功能。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JACK C VAUGHN其他文献
JACK C VAUGHN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JACK C VAUGHN', 18)}}的其他基金
ANALYSIS OF SEQUENCE DIVERGENCE IN TETRAPLOID RRNA GENES
四倍体RRNA基因序列差异分析
- 批准号:
3438452 - 财政年份:1986
- 资助金额:
$ 20.09万 - 项目类别:
相似国自然基金
长链非编码RNA AATBC结合并干扰SRSFs蛋白发生相分离调控RNA可变剪接促进三阴性乳腺癌耐药的机制研究
- 批准号:82273174
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
RNA结合蛋白KHSRP通过调控mRNA剪接抑制I型干扰素信号通路的机制研究
- 批准号:82271795
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
RNA结合蛋白RBM4通过靶向转录因子STAT1调控干扰素抗病毒功能及分子机制研究
- 批准号:82201949
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
RNA结合蛋白KHSRP通过调控mRNA剪接抑制I型干扰素信号通路的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:
RNA结合蛋白RBM4通过靶向转录因子STAT1调控干扰素抗病毒功能及分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
PcG Function of YY1 in Transcription and Development
YY1 在转录和发育中的 PcG 功能
- 批准号:
7031075 - 财政年份:2006
- 资助金额:
$ 20.09万 - 项目类别:
Integrated Genomic Analysis of a Drosophila Transcriptional Regulatory Network
果蝇转录调控网络的综合基因组分析
- 批准号:
7026230 - 财政年份:2006
- 资助金额:
$ 20.09万 - 项目类别:
Characterization of novel core promoter elements
新型核心启动子元件的表征
- 批准号:
7053624 - 财政年份:2006
- 资助金额:
$ 20.09万 - 项目类别:
Molecular Mechanism of Small RNA-induced RNA Silencing
小RNA诱导RNA沉默的分子机制
- 批准号:
7128693 - 财政年份:2006
- 资助金额:
$ 20.09万 - 项目类别: